Vanguard Group Inc

13F Holdings History for HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

Symbol: HRTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Ownership: 8.46M shares
Security Ownership: 4.61%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)

2025-10-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.46M shares of HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX). This represents 4.61% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	4.61%		$10.7M	8.46M			$1.26	13G/A	9/30/2025	30 Oct 2025 15:16:56

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%		$10.7M	8.46M	-11,676	-0.14%	$1.26	Q3 2025
6/30/2025	0%	+0%	$17.5M	8.47M	+245,875	+2.99%	$2.07	Q2 2025
3/31/2025	0%	+0%	$18.1M	8.23M	+67,976		$2.20	Q1 2025
12/31/2024	0%	0%	$12.5M	8.16M	-562,567	-6.45%	$1.53	Q4 2024
9/30/2024	0%	+0%	$17.4M	8.72M	+104,254	+1.21%	$1.99	Q3 2024
6/30/2024	0%	+0%	$30.2M	8.62M	+501,206	+6.18%	$3.50	Q2 2024
3/31/2024	0%	0%	$22.5M	8.11M	-224,196	-2.69%	$2.77	Q1 2024
12/31/2023	0%	+0%	$14.2M	8.34M	+169,632	+2.08%	$1.70	Q4 2023
9/30/2023	0%	+0%	$8.41M	8.17M	+28,558	+0.35%	$1.03	Q3 2023
6/30/2023	0%	0%	$9.44M	8.14M	-289,896	-3.44%	$1.16	Q2 2023
3/31/2023	0%	+0%	$12.7M	8.43M	+624,333	+8%	$1.51	Q1 2023
12/31/2022	0%	0%	$19.5M	7.81M	-946,556	-10.8%	$2.50	Q4 2022
9/30/2022	0%	+0%	$36.9M	8.75M	+790,644	+9.93%	$4.22	Q3 2022
6/30/2022	0%	0%	$22.2M	7.96M	-1,972,491	-19.9%	$2.79	Q2 2022
3/31/2022	0%	+0%	$56.8M	9.93M	+325,643	+3.39%	$5.72	Q1 2022
12/31/2021	0%	+0%	$87.7M	9.61M	+108,753	+1.14%	$9.13	Q4 2021
9/30/2021	0%	+0%	$102M	9.5M	+180,564	+1.94%	$10.69	Q3 2021
6/30/2021	0%	+0%	$145M	9.32M	+828,512	+9.76%	$15.52	Q2 2021
3/31/2021	0%	+0%	$138M	8.49M	+179,448	+2.16%	$16.21	Q1 2021
12/31/2020	0.01%	+0%	$176M	8.31M	+310,669	+3.88%	$21.17	Q4 2020
9/30/2020	0%	0%	$119M	8M	-28,439	-0.35%	$14.82	Q3 2020
6/30/2020	0%	+0%	$118M	8.03M	+45,073	+0.56%	$14.71	Q2 2020
3/31/2020	0%	+0%	$93.7M	7.98M	+127,899	+1.63%	$11.74	Q1 2020
12/31/2019	0.01%	+0%	$185M	7.86M	+900,519	+12.9%	$23.50	Q4 2019
9/30/2019	0%	+0%	$129M	6.96M	+211,189	+3.13%	$18.50	Q3 2019
6/30/2019	0%	+0%	$125M	6.74M	+330,351	+5.15%	$18.59	Q2 2019
3/31/2019	0.01%	+0%	$157M	6.41M	+100,168	+1.59%	$24.44	Q1 2019
12/31/2018	0.01%	+0%	$164M	6.31M	+121,090	+1.96%	$25.94	Q4 2018
9/30/2018	0.01%	+0%	$196M	6.19M	+1,661,318	+36.7%	$31.65	Q3 2018
6/30/2018	0.01%	+0%	$176M	4.53M	+1,734,743	+62%	$38.85	Q2 2018
3/31/2018	0%	+0%	$77.2M	2.8M	+379,908	+15.7%	$27.60	Q1 2018
12/31/2017	0%	+0%	$43.8M	2.42M	+347,787	+16.8%	$18.10	Q4 2017
9/30/2017	0%	0%	$33.4M	2.07M	-26,972	-1.29%	$16.15	Q3 2017
6/30/2017	0%	+0%	$29M	2.1M	+221,362	+11.8%	$13.85	Q2 2017
3/31/2017	0%	+0%	$28.1M	1.88M	+537,563	+40.2%	$15.00	Q1 2017
12/31/2016	0%	+0%	$17.5M	1.34M	+26,560	+2.03%	$13.10	Q4 2016
9/30/2016	0%	+0%	$22.6M	1.31M	+95,637	+7.87%	$17.23	Q3 2016
6/30/2016	0%	+0%	$21.9M	1.22M	+58,039	+5.02%	$18.05	Q2 2016
3/31/2016	0%	+0%	$22M	1.16M	+54,940	+4.98%	$18.99	Q1 2016
12/31/2015	0%	+0%	$29.4M	1.1M	+24,726	+2.29%	$26.70	Q4 2015
9/30/2015	0%	+0%	$26.3M	1.08M	+182,312	+20.4%	$24.40	Q3 2015
6/30/2015	0%	+0%	$27.9M	895K	+226,015	+33.8%	$31.16	Q2 2015
3/31/2015	0%	+0%	$9.74M	669K	+93,504	+16.2%	$14.55	Q1 2015
12/31/2014	0%	+0%	$5.79M	576K	+11,274	+2%	$10.06	Q4 2014
9/30/2014	0%	+0%	$4.7M	565K	+77,609	+15.9%	$8.33	Q3 2014
6/30/2014	0%	+0%	$6M	487K	+486,924	NEW	$12.32	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.